Crinetics Pharmaceuticals Inc. (CRNX) Rose 6.21% or 1.64 To Price $28.04 On Thursday


Crinetics Pharmaceuticals Inc. (CRNX) rose 6.21% or 1.64 to $28.04. It is close to 37246 shares traded, which is 70.06% compare to the average total volume 53161. The market cap of CRNX is $676.83 million. The year to date change is -3.72%. The 52 week price range is from $19.23 to $42.0. Price of CRNX have changed -0.41% during last week. It have changed -0.26% over last month, 8.46% over last 3 months, -24.12% over last 6 months and 7.71% over one year.

Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for CRNX is 24.83. It is -11.45% below current price. The 200-day Moving Averages for CRNX is 26.92. It is -3.99% below current price. The 52-week High is 42.0. It is 49.79% from the current price. The 52-week Low is 19.23. It is -31.42% from current price.

There are some statistics of CRNX. It is has market cap $676.83 million. The share outstanding is 24.14 million. The average volume is 53161. The percent of top 15 Institution holding is 95.20%. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of CRNX is -45.70%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of CRNX is -25.96%.


Tags:

Share this post